Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Jul 29. doi: 10.1038/s41565-019-0538-3. [Epub ahead of print]

PMID:
31358944
2.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, Neves JD, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Aug;14(8):811. doi: 10.1038/s41565-019-0523-x.

PMID:
31289407
3.

On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Jul;14(7):629-635. doi: 10.1038/s41565-019-0496-9. No abstract available. Erratum in: Nat Nanotechnol. 2019 Aug;14(8):811. Nat Nanotechnol. 2019 Jul 29;:.

PMID:
31270452
4.

Nanoparticle-mediated magnetic hyperthermia is an effective method for killing the human-infective protozoan parasite Leishmania mexicana in vitro.

Berry SL, Walker K, Hoskins C, Telling ND, Price HP.

Sci Rep. 2019 Jan 31;9(1):1059. doi: 10.1038/s41598-018-37670-9.

5.

A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines.

Alsuraifi A, Lin PKT, Curtis A, Lamprou DA, Hoskins C.

Pharmaceuticals (Basel). 2018 Sep 22;11(4). pii: E91. doi: 10.3390/ph11040091.

6.

Stimuli Responsive Polymeric Systems for Cancer Therapy.

Alsuraifi A, Curtis A, Lamprou DA, Hoskins C.

Pharmaceutics. 2018 Aug 22;10(3). pii: E136. doi: 10.3390/pharmaceutics10030136. Review.

7.

Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy.

Al-Shakarchi W, Alsuraifi A, Curtis A, Hoskins C.

Pharmaceutics. 2018 May 26;10(2). pii: E63. doi: 10.3390/pharmaceutics10020063.

8.

Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy.

Al-Shakarchi W, Alsuraifi A, Abed M, Abdullah M, Richardson A, Curtis A, Hoskins C.

Pharmaceutics. 2018 Apr 12;10(2). pii: E48. doi: 10.3390/pharmaceutics10020048.

9.

Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance.

Kumar M, Curtis A, Hoskins C.

Pharmaceutics. 2018 Jan 14;10(1). pii: E11. doi: 10.3390/pharmaceutics10010011. Review.

10.

Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents.

Zafar A, Pilkington LI, Haverkate NA, van Rensburg M, Leung E, Kumara S, Denny WA, Barker D, Alsuraifi A, Hoskins C, Reynisson J.

Molecules. 2018 Jan 11;23(1). pii: E145. doi: 10.3390/molecules23010145.

11.

The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery.

Moss DM, Curley P, Kinvig H, Hoskins C, Owen A.

Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):223-236. doi: 10.1080/17474124.2018.1399794. Epub 2017 Nov 8. Review.

PMID:
29088978
12.

Nanotechnologies in Pancreatic Cancer Therapy.

Manzur A, Oluwasanmi A, Moss D, Curtis A, Hoskins C.

Pharmaceutics. 2017 Sep 25;9(4). pii: E39. doi: 10.3390/pharmaceutics9040039. Review.

13.

Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy.

Oluwasanmi A, Al-Shakarchi W, Manzur A, Aldebasi MH, Elsini RS, Albusair MK, Haxton KJ, Curtis ADM, Hoskins C.

J Control Release. 2017 Nov 28;266:355-364. doi: 10.1016/j.jconrel.2017.09.027. Epub 2017 Sep 22.

PMID:
28943195
14.

Thermally triggered theranostics for pancreatic cancer therapy.

Malekigorji M, Alfahad M, Kong Thoo Lin P, Jones S, Curtis A, Hoskins C.

Nanoscale. 2017 Aug 31;9(34):12735-12745. doi: 10.1039/c7nr02751f.

PMID:
28829476
15.

Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.

de Wolf E, Abdullah MI, Jones SM, Menezes K, Moss DM, Drijfhout FP, Hart SR, Hoskins C, Stronach EA, Richardson A.

Sci Rep. 2017 Jul 14;7(1):5410. doi: 10.1038/s41598-017-05595-4.

16.

Drug development: Lessons from nature.

Mathur S, Hoskins C.

Biomed Rep. 2017 Jun;6(6):612-614. doi: 10.3892/br.2017.909. Epub 2017 May 9.

17.

Remotely triggered scaffolds for controlled release of pharmaceuticals.

Roach P, McGarvey DJ, Lees MR, Hoskins C.

Int J Mol Sci. 2013 Apr 19;14(4):8585-602. doi: 10.3390/ijms14048585.

18.

A review on comb-shaped amphiphilic polymers for hydrophobic drug solubilization.

Hoskins C, Thoo-Lin PK, Cheng WP.

Ther Deliv. 2012 Jan;3(1):59-79. Review.

PMID:
22833933
19.

Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance.

Riggio C, Calatayud MP, Hoskins C, Pinkernelle J, Sanz B, Torres TE, Ibarra MR, Wang L, Keilhoff G, Goya GF, Raffa V, Cuschieri A.

Int J Nanomedicine. 2012;7:3155-66. doi: 10.2147/IJN.S28460. Epub 2012 Jun 25.

20.

Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application.

Hoskins C, Min Y, Gueorguieva M, McDougall C, Volovick A, Prentice P, Wang Z, Melzer A, Cuschieri A, Wang L.

J Nanobiotechnology. 2012 Jun 25;10:27.

Supplemental Content

Loading ...
Support Center